1. Home
  2. ANL vs CATO Comparison

ANL vs CATO Comparison

Compare ANL & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANL
  • CATO
  • Stock Information
  • Founded
  • ANL 2004
  • CATO 1946
  • Country
  • ANL Cayman Islands
  • CATO United States
  • Employees
  • ANL N/A
  • CATO N/A
  • Industry
  • ANL
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • ANL
  • CATO Consumer Discretionary
  • Exchange
  • ANL Nasdaq
  • CATO Nasdaq
  • Market Cap
  • ANL 79.0M
  • CATO 71.1M
  • IPO Year
  • ANL 2023
  • CATO N/A
  • Fundamental
  • Price
  • ANL $2.25
  • CATO $3.27
  • Analyst Decision
  • ANL Strong Buy
  • CATO
  • Analyst Count
  • ANL 2
  • CATO 0
  • Target Price
  • ANL $9.00
  • CATO N/A
  • AVG Volume (30 Days)
  • ANL 5.8K
  • CATO 46.0K
  • Earning Date
  • ANL 03-04-2025
  • CATO 03-20-2025
  • Dividend Yield
  • ANL N/A
  • CATO 15.60%
  • EPS Growth
  • ANL N/A
  • CATO N/A
  • EPS
  • ANL N/A
  • CATO N/A
  • Revenue
  • ANL $5,000,000.00
  • CATO $666,779,000.00
  • Revenue This Year
  • ANL N/A
  • CATO N/A
  • Revenue Next Year
  • ANL N/A
  • CATO N/A
  • P/E Ratio
  • ANL N/A
  • CATO N/A
  • Revenue Growth
  • ANL N/A
  • CATO N/A
  • 52 Week Low
  • ANL $1.85
  • CATO $3.02
  • 52 Week High
  • ANL $17.48
  • CATO $6.70
  • Technical
  • Relative Strength Index (RSI)
  • ANL 57.33
  • CATO 38.30
  • Support Level
  • ANL $2.00
  • CATO $3.29
  • Resistance Level
  • ANL $2.15
  • CATO $3.63
  • Average True Range (ATR)
  • ANL 0.11
  • CATO 0.19
  • MACD
  • ANL 0.03
  • CATO 0.00
  • Stochastic Oscillator
  • ANL 59.52
  • CATO 19.61

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: